{"id":13272,"date":"2024-09-26T16:12:00","date_gmt":"2024-09-26T16:12:00","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/?post_type=webinar-and-podcast&#038;p=13272"},"modified":"2026-01-23T16:20:18","modified_gmt":"2026-01-23T16:20:18","slug":"ipscs-in-neuroscience-drug-discovery","status":"publish","type":"webinar-and-podcast","link":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/","title":{"rendered":"iPSCs in Neuroscience Drug Discovery"},"content":{"rendered":"\n<p>Induced pluripotent stem cells (iPSCs) are transforming how we model CNS disease. In this video, Dr Naheed (Max) Rohman Miraz, VP of Neuroscience at Sygnature Discovery, explores how iPSC-derived neurons and glial cells allow researchers to study disease-linked mechanisms directly in the cell types involved in pathology, including cells derived from patients. This offers a powerful route to investigating phenotypes, understanding variation, and building confidence in translational outcomes. <\/p>\n\n\n\n<h2 class=\"wp-block-heading has-text-2-xl-font-size\" style=\"padding-top:var(--wp--preset--spacing--40)\">What You&rsquo;ll Learn<\/h2>\n\n\n\n<ul style=\"padding-bottom:var(--wp--preset--spacing--40)\" class=\"wp-block-list\">\n<li>Why iPSCs offer a promising platform for modelling complex CNS disease<\/li>\n\n\n\n<li>How patient-derived cells support deeper biological insight<\/li>\n\n\n\n<li>Opportunities for screening and mechanism-led neuroscience <\/li>\n\n\n\n<li>How iPSCs complement a broader toolbox of translational model systems <\/li>\n<\/ul>\n\n\n<section class=\"Pegasus__Container w-full   relative h-fit  text-content-dark mobile-stacking-standard is-layout-flow wp-block-pegasus-container-is-layout-flow\" style=\"   \" >\n\t        \n\t\n\t\t\t\t\t\t\n\t\t        \t\t\n\t\t\t\t\t\t\t\n\t\t\t<div class=\"inner relative h-full is-flex-layout flex flex-col justify-start  w-full\">\n<section x-data=\"PegasusMediaBlock\" \n         class=\"Media object-contain w-full layout h-full\"\n         style=\"\">\n            \n                            \n\n            <div class=\"w-full h-0 relative \" style=\"padding-bottom: 56.25%\">\n            <iframe title=\"iPSCs in neuroscience drug discovery\" src=\"https:\/\/www.youtube.com\/embed\/IqYQAJirKZ4?feature=oembed&amp;rel=0&amp;autoplay=&amp;mute=&amp;muted=&amp;loop=&amp;controls=0\" width=\"640\" height=\"360\" loading=\"eager\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" class=\"video-embed w-full h-full absolute-center \" controls=\"0\"  frameborder=\"0\"><\/iframe>\n        <\/div>\n    \n    <div x-ref=\"videoPlaceholder\" class=\"absolute-center w-full !h-full\" @click=\"playVideo()\">\n        \n\n        <div class=\"preview-play-button absolute-center w-full h-full cursor-pointer\" title=\"Play Full Video\" @click=\"videoModalOpen = true\">\n            <button type=\"button\" class=\"absolute absolute-center w-16 h-16 bg-white\/80 rounded-full flex items-center justify-center\">\n                <span class=\"sr-only\">Play Full Video<\/span>\n                <svg width=\"17\" height=\"20\" viewBox=\"0 0 17 20\" fill=\"none\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\">\n                    <path d=\"M16.5 8.79609C17.1667 9.18099 17.1667 10.1432 16.5 10.5281L1.5 19.1884C0.833335 19.5733 9.70611e-07 19.0922 1.00426e-06 18.3224L1.76136e-06 1.00185C1.79501e-06 0.232054 0.833336 -0.24907 1.5 0.13583L16.5 8.79609Z\" fill=\"#002B46\"\/>\n                <\/svg>\n            <\/button>\n        <\/div>\n    <\/div>\n\n\n                \n            <\/section>\n<\/div>\n\t\t\n\t        <\/section>\n","protected":false},"excerpt":{"rendered":"<p>Could iPSCs be the breakthrough we need in neuroscience drug discovery?<\/p>\n","protected":false},"featured_media":13273,"template":"","category":[753,688],"resource_tag":[],"class_list":["post-13272","webinar-and-podcast","type-webinar-and-podcast","status-publish","has-post-thumbnail","hentry","category-neuroscience","category-therapeutic-areas"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Are iPSCs the Breakthrough for CNS Drug Discovery?<\/title>\n<meta name=\"description\" content=\"Discover how iPSC\u2011derived CNS cell models improve disease relevance, support patient\u2011driven screening, and strengthen clinical translation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Are iPSCs the Breakthrough for CNS Drug Discovery?\" \/>\n<meta property=\"og:description\" content=\"Discover how iPSC\u2011derived CNS cell models improve disease relevance, support patient\u2011driven screening, and strengthen clinical translation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-23T16:20:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/ipsc-breakthrough-neuroscience-drug-discovery-video.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/\",\"url\":\"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/\",\"name\":\"Are iPSCs the Breakthrough for CNS Drug Discovery?\",\"isPartOf\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/ipsc-breakthrough-neuroscience-drug-discovery-video.webp\",\"datePublished\":\"2024-09-26T16:12:00+00:00\",\"dateModified\":\"2026-01-23T16:20:18+00:00\",\"description\":\"Discover how iPSC\u2011derived CNS cell models improve disease relevance, support patient\u2011driven screening, and strengthen clinical translation.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/#primaryimage\",\"url\":\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/ipsc-breakthrough-neuroscience-drug-discovery-video.webp\",\"contentUrl\":\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/ipsc-breakthrough-neuroscience-drug-discovery-video.webp\",\"width\":1280,\"height\":720,\"caption\":\"Feature image for a video exploring how iPSCs enable disease\u2011relevant CNS models and improve confidence in neuroscience drug discovery.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"iPSCs in Neuroscience Drug Discovery\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#website\",\"url\":\"https:\/\/www.sygnaturediscovery.com\/fr\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#organization\",\"name\":\"Sygnature Discovery\",\"url\":\"https:\/\/www.sygnaturediscovery.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg\",\"contentUrl\":\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature Discovery\"},\"image\":{\"@id\":\"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Are iPSCs the Breakthrough for CNS Drug Discovery?","description":"Discover how iPSC\u2011derived CNS cell models improve disease relevance, support patient\u2011driven screening, and strengthen clinical translation.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/","og_locale":"fr_CA","og_type":"article","og_title":"Are iPSCs the Breakthrough for CNS Drug Discovery?","og_description":"Discover how iPSC\u2011derived CNS cell models improve disease relevance, support patient\u2011driven screening, and strengthen clinical translation.","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/","og_site_name":"Sygnature","article_modified_time":"2026-01-23T16:20:18+00:00","og_image":[{"width":1280,"height":720,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/ipsc-breakthrough-neuroscience-drug-discovery-video.webp","type":"image\/webp"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimation du temps de lecture":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/","name":"Are iPSCs the Breakthrough for CNS Drug Discovery?","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/#primaryimage"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/ipsc-breakthrough-neuroscience-drug-discovery-video.webp","datePublished":"2024-09-26T16:12:00+00:00","dateModified":"2026-01-23T16:20:18+00:00","description":"Discover how iPSC\u2011derived CNS cell models improve disease relevance, support patient\u2011driven screening, and strengthen clinical translation.","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/#primaryimage","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/ipsc-breakthrough-neuroscience-drug-discovery-video.webp","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2026\/01\/ipsc-breakthrough-neuroscience-drug-discovery-video.webp","width":1280,"height":720,"caption":"Feature image for a video exploring how iPSCs enable disease\u2011relevant CNS models and improve confidence in neuroscience drug discovery."},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/webinar-and-podcast\/ipscs-in-neuroscience-drug-discovery\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/"},{"@type":"ListItem","position":2,"name":"iPSCs in Neuroscience Drug Discovery"}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature Discovery","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature Discovery"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/webinar-and-podcast\/13272","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/webinar-and-podcast"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/webinar-and-podcast"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/webinar-and-podcast\/13272\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media\/13273"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=13272"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=13272"},{"taxonomy":"resource_tag","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/resource_tag?post=13272"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}